Publication:
IL7RA polymorphisms are not associated with AIDS progression

dc.contributor.authorMedrano, Luz Maria
dc.contributor.authorJiménez, José Luis
dc.contributor.authorJimenez-Sousa, Maria Angeles
dc.contributor.authorFernández-Rodíguez, Amanda
dc.contributor.authorGutiérrez-Rivas, Mónica
dc.contributor.authorBellón, José María
dc.contributor.authorBlanco, José Ramón
dc.contributor.authorInciarte, Alexy
dc.contributor.authorMuñoz-Fernández, María Ángeles
dc.contributor.authorResino, Salvador
dc.contributor.funderAgencia Estatal de Investigación (España)
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderRedes Temáticas de Investigación Cooperativa en Salud (RETICS) (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderPrograma Iberoamericano de Ciencia y Tecnología para el Desarrollo (España)
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERBBN (Bioingeniería, Biomateriales y Nanomedicina)
dc.contributor.funderUnión Europea. Comisión Europea. 7 Programa Marco
dc.contributor.funderMinisterio de Ciencia y Universidades (España)
dc.date.accessioned2024-05-22T07:44:45Z
dc.date.available2024-05-22T07:44:45Z
dc.date.issued2017-10
dc.description.abstractBackground: Our aim was to determine whether α-chain of the IL-7 receptor (IL7RA) polymorphisms (rs10491434, rs6897932 and rs987106) are associated with the clinical pattern of AIDS progression in ART-naïve HIV-infected patients. Materials and methods: We carried out a cross-sectional study in 673 HIV-infected patients who were classified into three groups according to the clinical pattern of AIDS progression (188 long-term nonprogressors (LTNPs), 334 moderate progressors (MPs) and 151 rapid progressors (RPs)). Additionally, 134 healthy blood donors participated as a Control-group. We selected three IL7RA polymorphisms located at three regulatory regions [rs6897932 (exon 6), rs987106 (intronic region) and rs10491434 (3'UTR)]. DNA genotyping was performed using Sequenom's MassARRAY platform. Results: The Control-group and all HIV-infected patients had similar age and percentage of males. LTNP-group was older at HIV diagnosis and at the inclusion in the study and had higher percentage of intravenous drug users (IDU) (P < 0·001). Besides, LTNP-group had lower proportion of male patients and homosexual HIV transmission than MP and RP groups (P < 0·001). Moreover, similar values of allelic, genotypic and haplotype frequencies for IL7RA polymorphisms were found between healthy controls and HIV-infected patients (P > 0·05), and among different subgroups of HIV patients according to AIDS progression (LTNPs, MPs and RPs) (P > 0·05). The adjusted logistic regression did not show any significant association between IL7RA polymorphisms and AIDS progression. Conclusions: IL7RA polymorphisms (rs6897932, rs987106 and rs10491434) were not associated with AIDS progression in Spanish population. Therefore, IL7RA polymorphisms do not seem to help us to understand HIV pathogenesis in untreated HIV-infected patients with different clinical evolution.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work has been (partially) funded by the RD12/0017/0037 and RD12/0017/0024 projects as part of the Acción Estratégica en Salud, Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008–2011 and cofinanced by Instituto de Salud Carlos III (Subdirección General de Evaluación) and Fondo Europeo de Desarrollo Regional (FEDER), RETIC PT13/0010/0028, Fondo de Investigación Sanitaria (FIS) (grant numbers PI13/02016, PI14/00882, PI14CIII/00011), Comunidad de Madrid (grant numbers S-2010/BMD-2351 and S-2010/BMD-2332), Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo (CYTED) (grant numbers 214RT0482), and the ‘Programa de Investigación de la Consejería de Sanidad de la Comunidad de Madrid’ to JLJ.CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, the Consolider Programand CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. This work was supported partially by a Marie Curie International Research Staff Exchange Scheme Fellow-ship within the 7th European Community Framework Program, project No. PIRSES-GA-2012-316730 NANOGENE and cofinanced by the Polish Ministry of Science and Higher Education (grant No. W21/7PR/2013). LMM, MAJS and AFR are supported by ‘Instituto de Salud Carlos III’ [grant numbers CD14/00002, CD13/00013 and CP14/0010, respectively].es_ES
dc.format.number10es_ES
dc.format.page719-727es_ES
dc.format.volume47es_ES
dc.identifier.citationEur J Clin Invest. 2017 Oct;47(10):719-727.es_ES
dc.identifier.doi10.1111/eci.12797es_ES
dc.identifier.e-issn1365-2362es_ES
dc.identifier.journalEuropean journal of clinical investigationes_ES
dc.identifier.pubmedID28796293es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19515
dc.language.isoenges_ES
dc.publisherWiley
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD12%2F0017%2F0037/ES/SIDA/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD12%2F0017%2F0024/ES/SIDA/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PI13%2F02016/ES/Desarrollo y mecanismo de acción de dendrímeros como microbicidas para frenar la infección por el VIH por transmisión sexual (vaginal y anal): prueba de concepto/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PI14%2F00882/ES/Prevención de la transmisión del VIH mediante el uso de la nanotecnología dirigida frente a proteínas virales, receptores celulares y DC-SIGN/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//CD14%2F00002/ES/CD14%2F00002/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CD13/00013es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//CP14%2F00100/ES/CP14%2F00100/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PT13%2F0010%2F0028/ES/Plataforma de Biobancos/es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/null/null/ISCIII Subprograma de proyectos de investigacion en salud . Modalidad proyectos en salud. (2014)/PI14CIII/00011es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/316730/EUes_ES
dc.relation.publisherversionhttps://doi.org/10.1111/eci.12797es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAcquired immunodeficiency syndromees_ES
dc.subjectIL7RAes_ES
dc.subjectLong-term nonprogressorses_ES
dc.subjectProgressiones_ES
dc.subjectSinglenucleotide polymorphismses_ES
dc.subject.meshGene Expression Regulationes_ES
dc.subject.meshPolymorphism, Single Nucleotidees_ES
dc.subject.meshAcquired Immunodeficiency Syndromees_ES
dc.subject.meshAdultes_ES
dc.subject.meshAge Factorses_ES
dc.subject.meshCross-Sectional Studieses_ES
dc.subject.meshDisease Progressiones_ES
dc.subject.meshFemalees_ES
dc.subject.meshHIV Infectionses_ES
dc.subject.meshHumanses_ES
dc.subject.meshInterleukin-7 Receptor alpha Subunites_ES
dc.subject.meshLogistic Modelses_ES
dc.subject.meshMalees_ES
dc.subject.meshMiddle Agedes_ES
dc.subject.meshPrognosises_ES
dc.subject.meshReference Valueses_ES
dc.subject.meshRisk Assessmentes_ES
dc.titleIL7RA polymorphisms are not associated with AIDS progressiones_ES
dc.typeresearch articlees_ES
dc.type.hasVersionAMes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication358a1c6d-3f44-4ee0-b523-dedc5a675f6b
relation.isAuthorOfPublication2bf7faec-7f00-44ba-9494-efb396305551
relation.isAuthorOfPublication89b17350-14e3-4dfd-b797-6ee6ca5363b8
relation.isAuthorOfPublication.latestForDiscovery358a1c6d-3f44-4ee0-b523-dedc5a675f6b
relation.isFunderOfPublication54733407-1d78-4c44-bf4c-8c8a7592aa4b
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublicatione5587d0c-5866-4a4c-b5bf-93dec31ae4ed
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationc87c70a3-e023-4b6b-ac25-1b2d1b483786
relation.isFunderOfPublication908b0883-1a3f-453e-8f35-6cb1aebef984
relation.isFunderOfPublicationabf13423-2ad9-4fcc-9d6a-9df884a10872
relation.isFunderOfPublication453a1d63-c349-4a0e-b0f2-f4edba065c75
relation.isFunderOfPublication6544a51b-1e06-4f2b-a7ec-42488cd60223
relation.isFunderOfPublication.latestForDiscovery54733407-1d78-4c44-bf4c-8c8a7592aa4b
relation.isPublisherOfPublicationd81e762a-95f7-4917-88a1-8004b3b8caa7
relation.isPublisherOfPublication.latestForDiscoveryd81e762a-95f7-4917-88a1-8004b3b8caa7

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
IL7RA_PolymorphismsNotAssociatedAIDS_2017.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format
Description: